AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE

AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE was reported 237 times

AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BEZOLD ABSCESS 1 0.1429
1 PYLOROSPASM 1 0.0455
2 ARTERIAL STENOSIS LIMB 1 0.0196
3 ELEPHANTIASIS 1 0.0149
4 ANAESTHETIC COMPLICATION CARDIAC 1 0.0145
5 LUDWIG ANGINA 1 0.0069
6 SOCIOECONOMIC PRECARITY 1 0.0058
7 PROCEDURAL HYPERTENSION 1 0.0053
8 DEAFNESS PERMANENT 1 0.0051
9 GLOMERULONEPHRITIS ACUTE 1 0.0049
10 PERIPHERAL NERVE OPERATION 1 0.0046
11 VAGINAL MYCOSIS 1 0.0043
12 INFESTATION 1 0.0039
13 PANCREATIC INJURY 1 0.0033
14 CAUSTIC INJURY 1 0.0032
15 OESOPHAGEAL ACHALASIA 2 0.0031
16 EAR OPERATION 1 0.0027
17 MESOTHELIOMA MALIGNANT 1 0.0027
18 VERTEBRAL OSTEOPHYTE 1 0.0023
19 VULVOVAGINAL RASH 1 0.0023
20 BLEPHARAL PIGMENTATION 1 0.0020
21 FAECAL VOLUME INCREASED 1 0.0019
22 SCAPULA FRACTURE 1 0.0019
23 RETROPERITONEAL LYMPHADENOPATHY 1 0.0019
24 INSTILLATION SITE REACTION 2 0.0018
25 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
26 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
27 SACRAL PAIN 1 0.0016
28 MITRAL VALVE CALCIFICATION 1 0.0016
29 HYPOTRICHOSIS 1 0.0016
30 INJECTION SITE EXFOLIATION 1 0.0015
31 BORDERLINE PERSONALITY DISORDER 1 0.0014
32 WITHDRAWAL BLEED 1 0.0014
33 BACTERIAL DISEASE CARRIER 1 0.0014
34 ASPIRATION PLEURAL CAVITY 1 0.0013
35 ENDOCARDITIS BACTERIAL 1 0.0013
36 OCULAR VASCULAR DISORDER 1 0.0012
37 ADRENAL MASS 1 0.0012
38 BILIARY DYSKINESIA 2 0.0012
39 ENDOCRINE OPHTHALMOPATHY 1 0.0012
40 ABDOMINAL LYMPHADENOPATHY 1 0.0012
41 OESOPHAGEAL OBSTRUCTION 1 0.0012
42 FOLLICULAR LYMPHOMA 1 0.0011
43 ABDOMINAL SEPSIS 1 0.0011
44 MUSCLE CRAMP 2 0.0011
45 LIGAMENT DISORDER 1 0.0011
46 LIPOATROPHY 1 0.0011
47 DUODENAL PERFORATION 1 0.0010
48 SKIN OEDEMA 1 0.0010
49 ONYCHALGIA 1 0.0010
50 RENAL MASS 2 0.0010
51 NASAL INFLAMMATION 1 0.0009
52 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
53 NAIL GROWTH ABNORMAL 1 0.0009
54 DILATATION ATRIAL 1 0.0009
55 INFREQUENT BOWEL MOVEMENTS 2 0.0008
56 AUDITORY DISORDER 1 0.0007
57 SEBORRHOEIC KERATOSIS 1 0.0007
58 REBOUND ACID HYPERSECRETION 2 0.0007
59 NEPHROGENIC ANAEMIA 3 0.0006
60 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
61 TINEA PEDIS 1 0.0006
62 OROPHARYNGEAL BLISTERING 1 0.0006
63 EROSIVE OESOPHAGITIS 1 0.0006
64 CAROTID ARTERY STENOSIS 2 0.0006
65 DRUG SCREEN NEGATIVE 1 0.0006
66 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
67 MOTION SICKNESS 1 0.0005
68 VOCAL CORD DISORDER 1 0.0005
69 PHYSICAL ASSAULT 1 0.0005
70 BODY HEIGHT DECREASED 5 0.0005
71 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
72 DANDRUFF 1 0.0005
73 GASTROINTESTINAL ULCER 1 0.0005
74 APPLICATION SITE URTICARIA 1 0.0004
75 CYTOMEGALOVIRUS COLITIS 1 0.0004
76 BREAKTHROUGH PAIN 1 0.0004
77 PUSTULE 1 0.0004
78 INSTILLATION SITE PAIN 1 0.0004
79 HYPERPARATHYROIDISM SECONDARY 1 0.0004
80 VENTRICULAR HYPERTROPHY 1 0.0004
81 RETINAL ARTERY OCCLUSION 1 0.0004
82 BLOOD POTASSIUM ABNORMAL 1 0.0004
83 TRICHORRHEXIS 1 0.0004
84 JOINT LOCK 1 0.0004
85 IMPAIRED DRIVING ABILITY 4 0.0004
86 PHARYNGEAL DISORDER 1 0.0003
87 DYSCHEZIA 1 0.0003
88 MEDICAL DEVICE DISCOMFORT 1 0.0003
89 MASTICATION DISORDER 1 0.0003
90 EYELIDS PRURITUS 1 0.0003
91 PRE-EXISTING CONDITION IMPROVED 2 0.0003
92 CARDIAC FLUTTER 2 0.0003
93 DEAFNESS NEUROSENSORY 1 0.0003
94 WOUND DEHISCENCE 1 0.0003
95 ULCER HAEMORRHAGE 2 0.0003
96 HANGOVER 1 0.0003
97 THERMAL BURN 2 0.0003
98 SKIN WEEPING 1 0.0003
99 FREEZING PHENOMENON 1 0.0003
100 ORAL INFECTION 1 0.0003
101 WOUND SECRETION 1 0.0003
102 PROSTATOMEGALY 1 0.0003
103 AZOTAEMIA 1 0.0003
104 SPINAL COMPRESSION FRACTURE 2 0.0002
105 SOCIAL PROBLEM 1 0.0002
106 THYROID FUNCTION TEST ABNORMAL 1 0.0002
107 SLEEP TERROR 1 0.0002
108 TONGUE DISCOMFORT 1 0.0002
109 PURULENT DISCHARGE 1 0.0002
110 HORDEOLUM 1 0.0002
111 CHAPPED LIPS 1 0.0002
112 ONYCHOMYCOSIS 1 0.0002
113 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
114 EXOSTOSIS 2 0.0002
115 ARTHRITIS INFECTIVE 1 0.0002
116 GASTRITIS EROSIVE 1 0.0002
117 SKIN TIGHTNESS 1 0.0002
118 BLOOD PROLACTIN INCREASED 1 0.0002
119 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
120 VULVOVAGINAL PAIN 1 0.0002
121 PROTEIN URINE PRESENT 1 0.0002
122 HEPATIC ENZYME ABNORMAL 1 0.0002
123 VEIN DISORDER 1 0.0002
124 CORONARY ARTERY STENOSIS 1 0.0002
125 VULVOVAGINAL PRURITUS 1 0.0002
126 SKIN NECROSIS 1 0.0002
127 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
128 OVERWEIGHT 1 0.0002
129 ERYTHEMA OF EYELID 1 0.0002
130 BIPOLAR DISORDER 2 0.0002
131 ASTHENOPIA 1 0.0002
132 STREPTOCOCCAL INFECTION 1 0.0002
133 NECROSIS 1 0.0002
134 INTRACRANIAL PRESSURE INCREASED 1 0.0002
135 APPLICATION SITE PRURITUS 4 0.0002
136 CHOLECYSTECTOMY 2 0.0002
137 HYPERVENTILATION 1 0.0002
138 METABOLIC DISORDER 1 0.0002
139 PRODUCT LABEL CONFUSION 1 0.0002
140 SINUS HEADACHE 1 0.0002
141 PROTHROMBIN TIME PROLONGED 1 0.0002
142 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
143 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
144 INJECTION SITE VESICLES 1 0.0002
145 FOREIGN BODY SENSATION IN EYES 1 0.0002
146 POOR QUALITY DRUG ADMINISTERED 1 0.0002
147 TENDON DISORDER 1 0.0002
148 POLYP 1 0.0002
149 WALKING AID USER 1 0.0002
150 PRODUCT FORMULATION ISSUE 1 0.0002
151 SKIN MASS 1 0.0001
152 CHOLECYSTITIS CHRONIC 1 0.0001
153 IMPAIRED GASTRIC EMPTYING 2 0.0001
154 BLOOD TESTOSTERONE DECREASED 1 0.0001
155 INFARCTION 1 0.0001
156 CHRONIC KIDNEY DISEASE 11 0.0001
157 DROOLING 1 0.0001
158 HAIR GROWTH ABNORMAL 1 0.0001
159 HUNGER 2 0.0001
160 EXTRASYSTOLES 1 0.0001
161 DEFAECATION URGENCY 1 0.0001
162 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
163 APPLICATION SITE REACTION 1 0.0001
164 PRODUCT SUPPLY ISSUE 1 0.0001
165 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
166 POOR QUALITY SLEEP 3 0.0001
167 SKIN HAEMORRHAGE 2 0.0001
168 SUNBURN 1 0.0001
169 HAIR DISORDER 1 0.0001
170 EYE PRURITUS 4 0.0001
171 PARANOIA 2 0.0001
172 APPLICATION SITE ERYTHEMA 3 0.0001
173 NAIL DISORDER 1 0.0001
174 RESPIRATORY RATE INCREASED 1 0.0001
175 END STAGE RENAL DISEASE 2 0.0001
176 PNEUMONIA BACTERIAL 1 0.0001
177 BLOOD CHOLESTEROL INCREASED 5 0.0001
178 DIARRHOEA HAEMORRHAGIC 1 0.0001
179 FLANK PAIN 1 0.0001
180 HEPATIC CIRRHOSIS 2 0.0001
181 PHOTOPHOBIA 2 0.0001
182 ARTERIOSCLEROSIS 1 0.0001
183 EYE IRRITATION 6 0.0001
184 ACUTE RESPIRATORY FAILURE 2 0.0001
185 DIZZINESS POSTURAL 1 0.0001
186 PHARYNGEAL SWELLING 1 0.0001
187 LIGAMENT SPRAIN 1 0.0001
188 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
189 SPINAL FRACTURE 2 0.0001
190 SKELETAL INJURY 1 0.0001
191 HYPERBILIRUBINAEMIA 1 0.0001
192 EYE DISCHARGE 1 0.0001
193 IMPAIRED WORK ABILITY 2 0.0001
194 DECREASED ACTIVITY 1 0.0001
195 BLOOD GLUCOSE FLUCTUATION 1 0.0001
196 GASTROINTESTINAL PAIN 1 0.0001
197 FOOT DEFORMITY 1 0.0001
198 SKIN DISORDER 3 0.0001
199 SNEEZING 2 0.0001
200 EYE INFECTION 1 0.0001
201 HEART RATE IRREGULAR 2 0.0001
202 MITRAL VALVE INCOMPETENCE 1 0.0001
203 NEOPLASM 1 0.0001
204 MADAROSIS 1 0.0001
205 EYELID OEDEMA 1 0.0001
206 VASCULITIS 1 0.0001
207 MENTAL IMPAIRMENT 2 0.0001
208 BURSITIS 1 0.0001
209 SCHIZOPHRENIA 1 0.0001
210 INJECTION SITE EXTRAVASATION 1 0.0001
211 CYST 1 0.0001
212 ILEUS 1 0.0001
213 SECRETION DISCHARGE 1 0.0001
214 PRODUCT USE ISSUE 15 0.0001
215 INTESTINAL OBSTRUCTION 3 0.0001
216 INJECTION SITE IRRITATION 1 0.0001
217 THERAPY CESSATION 4 0.0001
218 HIATUS HERNIA 1 0.0001
219 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
220 ORAL CANDIDIASIS 1 0.0001
221 RENAL FAILURE 10 0.0001
222 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
223 FEAR 2 0.0001
224 APPLICATION SITE RASH 1 0.0001
225 ORAL DISCOMFORT 1 0.0001
226 DIALYSIS 1 0.0001
227 IMPAIRED QUALITY OF LIFE 1 0.0001
228 PARAESTHESIA ORAL 1 0.0001
229 MYELODYSPLASTIC SYNDROME 1 0.0001
230 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
231 URINARY INCONTINENCE 2 0.0001
232 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
233 THROAT IRRITATION 3 0.0001
234 HYPOAESTHESIA ORAL 1 0.0001
235 LACRIMATION INCREASED 2 0.0001
236 CORONARY ARTERY DISEASE 2 0.0001
237 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
238 DEVICE FAILURE 1 0.0001
239 ACUTE KIDNEY INJURY 10 0.0001
240 HIP ARTHROPLASTY 1 0.0001
241 MUSCULOSKELETAL CHEST PAIN 1 0.0001
242 DELUSION 1 0.0001
243 EJECTION FRACTION DECREASED 1 0.0001
244 MOVEMENT DISORDER 2 0.0001
245 BLOOD POTASSIUM INCREASED 1 0.0001
246 IMPAIRED HEALING 2 0.0001
247 MANIA 1 0.0001
248 EXPIRED PRODUCT ADMINISTERED 2 0.0001
249 HEMIPARESIS 1 0.0001
250 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
251 MULTI-ORGAN FAILURE 1 0.0001
252 DEVICE DEFECTIVE 1 0.0001
253 INTENTIONAL PRODUCT MISUSE 5 0.0001
254 HEART RATE DECREASED 2 0.0001
255 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
256 GALLBLADDER DISORDER 1 0.0001
257 GOUT 1 0.0001
258 TOOTHACHE 1 0.0001
259 DRUG EFFECT INCOMPLETE 2 0.0001
260 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
261 DYSPNOEA EXERTIONAL 2 0.0001
262 FLATULENCE 3 0.0001
263 COLITIS 2 0.0001
264 BLOOD URINE PRESENT 1 0.0001
265 SLEEP APNOEA SYNDROME 1 0.0001
266 INCREASED APPETITE 1 0.0001
267 PULMONARY FIBROSIS 1 0.0001
268 POST PROCEDURAL COMPLICATION 1 0.0001
269 DRUG PRESCRIBING ERROR 1 0.0001
270 ERUCTATION 1 0.0001
271 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
272 SINUS DISORDER 1 0.0001
273 CONSTIPATION 11 0.0001
274 PRODUCT ADMINISTRATION ERROR 1 0.0000
275 FEEDING DISORDER 1 0.0000
276 OSTEOPOROSIS 2 0.0000
277 RIB FRACTURE 1 0.0000
278 PULMONARY HYPERTENSION 1 0.0000
279 DERMATITIS 1 0.0000
280 HALLUCINATION, VISUAL 1 0.0000
281 RENAL FAILURE ACUTE 2 0.0000
282 JOINT INJURY 1 0.0000
283 RECTAL HAEMORRHAGE 2 0.0000
284 SEPTIC SHOCK 2 0.0000
285 APPLICATION SITE PAIN 1 0.0000
286 STEVENS-JOHNSON SYNDROME 1 0.0000
287 GLOSSODYNIA 1 0.0000
288 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
289 TINNITUS 2 0.0000
290 MUSCLE TWITCHING 1 0.0000
291 PERICARDIAL EFFUSION 1 0.0000
292 COGNITIVE DISORDER 2 0.0000
293 INJURY 3 0.0000
294 SLEEP DISORDER 3 0.0000
295 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
296 OCULAR HYPERAEMIA 2 0.0000
297 DISEASE RECURRENCE 2 0.0000
298 BLOOD PRESSURE FLUCTUATION 1 0.0000
299 DIABETIC KETOACIDOSIS 1 0.0000
300 ENCEPHALOPATHY 1 0.0000
301 ABASIA 1 0.0000
302 DYSGEUSIA 3 0.0000
303 WEIGHT INCREASED 9 0.0000
304 PNEUMONIA ASPIRATION 1 0.0000
305 CELLULITIS 2 0.0000
306 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
307 DEPRESSION 9 0.0000
308 ABDOMINAL PAIN LOWER 1 0.0000
309 GASTRIC CANCER 1 0.0000
310 PRODUCT COMPLAINT 1 0.0000
311 HAEMATEMESIS 1 0.0000
312 ANXIETY 11 0.0000
313 HAEMATOMA 1 0.0000
314 NERVOUSNESS 2 0.0000
315 MUSCULOSKELETAL PAIN 2 0.0000
316 GASTRITIS 1 0.0000
317 HYPERSENSITIVITY 7 0.0000
318 EAR INFECTION 1 0.0000
319 BREAST CANCER FEMALE 1 0.0000
320 MENSTRUATION IRREGULAR 1 0.0000
321 JAUNDICE 1 0.0000
322 DRY MOUTH 3 0.0000
323 LIMB INJURY 1 0.0000
324 PALLOR 1 0.0000
325 DRUG DOSE OMISSION 6 0.0000
326 RESPIRATORY DISTRESS 1 0.0000
327 ABNORMAL DREAMS 1 0.0000
328 PROCEDURAL PAIN 1 0.0000
329 NECK PAIN 2 0.0000
330 ABDOMINAL DISCOMFORT 6 0.0000
331 MUSCULAR WEAKNESS 4 0.0000
332 LETHARGY 2 0.0000
333 DYSSTASIA 1 0.0000
334 MUSCULOSKELETAL STIFFNESS 3 0.0000
335 ASCITES 1 0.0000
336 ABDOMINAL PAIN UPPER 7 0.0000
337 CATARACT 2 0.0000
338 RESPIRATORY DISORDER 1 0.0000
339 IRRITABILITY 2 0.0000
340 PLEURAL EFFUSION 2 0.0000
341 BLOOD PRESSURE INCREASED 5 0.0000
342 EMOTIONAL DISORDER 1 0.0000
343 GYNAECOMASTIA 1 0.0000
344 COUGH 9 0.0000
345 SWELLING 3 0.0000
346 NERVOUS SYSTEM DISORDER 1 0.0000
347 SWOLLEN TONGUE 1 0.0000
348 HEAD INJURY 1 0.0000
349 HYPOTHYROIDISM 1 0.0000
350 HIP FRACTURE 1 0.0000
351 SWELLING FACE 2 0.0000
352 DYSPEPSIA 3 0.0000
353 EYE DISORDER 1 0.0000
354 HEART RATE INCREASED 3 0.0000
355 VISUAL ACUITY REDUCED 1 0.0000
356 FALL 10 0.0000
357 LIP SWELLING 1 0.0000
358 FUNGAL INFECTION 1 0.0000
359 GAIT INABILITY 1 0.0000
360 TYPE 2 DIABETES MELLITUS 1 0.0000
361 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
362 PRODUCT QUALITY ISSUE 4 0.0000
363 HEPATIC ENZYME INCREASED 2 0.0000
364 GASTRIC DISORDER 1 0.0000
365 VISION BLURRED 4 0.0000
366 ABDOMINAL DISTENSION 3 0.0000
367 WEIGHT DECREASED 8 0.0000
368 BURNING SENSATION 2 0.0000
369 HYPERKALAEMIA 1 0.0000
370 HYPERTENSION 6 0.0000
371 CRYING 1 0.0000
372 RESTLESSNESS 1 0.0000
373 MUSCLE SPASMS 5 0.0000
374 DYSURIA 1 0.0000
375 PAIN IN EXTREMITY 8 0.0000
376 INJECTION SITE MASS 1 0.0000
377 EYE SWELLING 1 0.0000
378 HEPATIC FUNCTION ABNORMAL 1 0.0000
379 DYSPNOEA 15 0.0000
380 INSOMNIA 7 0.0000
381 INJECTION SITE SWELLING 2 0.0000
382 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
383 BACK PAIN 6 0.0000
384 PALPITATIONS 3 0.0000
385 ARTHRITIS 2 0.0000
386 ABNORMAL BEHAVIOUR 1 0.0000
387 DISORIENTATION 1 0.0000
388 CARDIAC FAILURE 2 0.0000
389 CARDIAC FAILURE CONGESTIVE 2 0.0000
390 SOMNOLENCE 5 0.0000
391 EXTRA DOSE ADMINISTERED 1 0.0000
392 OEDEMA PERIPHERAL 3 0.0000
393 BLINDNESS 1 0.0000
394 NEUTROPHIL COUNT DECREASED 1 0.0000
395 INFLUENZA LIKE ILLNESS 2 0.0000
396 INJECTION SITE ERYTHEMA 3 0.0000
397 DIZZINESS 12 0.0000
398 ARTHRALGIA 10 0.0000
399 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
400 CARDIO-RESPIRATORY ARREST 1 0.0000
401 ROAD TRAFFIC ACCIDENT 1 0.0000
402 URTICARIA 4 0.0000
403 LOSS OF CONSCIOUSNESS 3 0.0000
404 MENTAL DISORDER 1 0.0000
405 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
406 LIVER DISORDER 1 0.0000
407 DEHYDRATION 3 0.0000
408 ADVERSE DRUG REACTION 2 0.0000
409 THERAPY NON-RESPONDER 1 0.0000
410 SUICIDAL IDEATION 2 0.0000
411 NASOPHARYNGITIS 4 0.0000
412 HYPOKALAEMIA 1 0.0000
413 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
414 ABDOMINAL PAIN 5 0.0000
415 CARDIAC DISORDER 2 0.0000
416 ARRHYTHMIA 1 0.0000
417 DYSPHAGIA 2 0.0000
418 PULMONARY EMBOLISM 2 0.0000
419 PRODUCTIVE COUGH 1 0.0000
420 MULTIPLE SCLEROSIS 1 0.0000
421 GAIT DISTURBANCE 4 0.0000
422 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
423 PRURITUS 8 0.0000
424 CONTUSION 2 0.0000
425 ATRIAL FIBRILLATION 2 0.0000
426 ALOPECIA 4 0.0000
427 DRY EYE 1 0.0000
428 SYNCOPE 2 0.0000
429 FLUID RETENTION 1 0.0000
430 CHEST DISCOMFORT 2 0.0000
431 ERYTHEMA 4 0.0000
432 FATIGUE 15 0.0000
433 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
434 HEADACHE 12 0.0000
435 OEDEMA 1 0.0000
436 TREMOR 3 0.0000
437 ARTHROPATHY 1 0.0000
438 PAIN 11 0.0000
439 PANCYTOPENIA 1 0.0000
440 BLISTER 1 0.0000
441 HYPONATRAEMIA 1 0.0000
442 EYE PAIN 1 0.0000
443 CEREBROVASCULAR ACCIDENT 3 0.0000
444 INCORRECT DOSE ADMINISTERED 4 0.0000
445 PRODUCT SUBSTITUTION ISSUE 1 0.0000
446 MYOCARDIAL INFARCTION 3 0.0000
447 DYSPHONIA 1 0.0000
448 BONE PAIN 1 0.0000
449 NASAL CONGESTION 1 0.0000
450 JOINT SWELLING 2 0.0000
451 EMOTIONAL DISTRESS 2 0.0000
452 THERAPEUTIC RESPONSE DECREASED 1 0.0000
453 DISCOMFORT 1 0.0000
454 FEELING HOT 1 0.0000
455 CHEST PAIN 3 0.0000
456 RASH 7 0.0000
457 ASTHENIA 6 0.0000
458 RHINORRHOEA 1 0.0000
459 PNEUMONIA 5 0.0000
460 DEEP VEIN THROMBOSIS 1 0.0000
461 BLOOD PRESSURE DECREASED 1 0.0000
462 DRY SKIN 2 0.0000
463 NEOPLASM MALIGNANT 1 0.0000
464 HYPOTENSION 3 0.0000
465 VOMITING 7 0.0000
466 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
467 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
468 SKIN BURNING SENSATION 1 0.0000
469 OVERDOSE 3 0.0000
470 INFECTION 2 0.0000
471 UNDERDOSE 1 0.0000
472 DRUG INEFFECTIVE 18 0.0000
473 BRONCHITIS 1 0.0000
474 HYPOAESTHESIA 2 0.0000
475 HALLUCINATION 1 0.0000
476 HOT FLUSH 1 0.0000
477 UNEVALUABLE EVENT 1 0.0000
478 DIABETES MELLITUS 1 0.0000
479 DECREASED APPETITE 3 0.0000
480 PARAESTHESIA 2 0.0000
481 NAUSEA 10 0.0000
482 INJECTION SITE BRUISING 1 0.0000
483 INJECTION SITE HAEMORRHAGE 1 0.0000
484 FEELING ABNORMAL 3 0.0000
485 SKIN EXFOLIATION 1 0.0000
486 MYALGIA 2 0.0000
487 URINARY TRACT INFECTION 2 0.0000
488 PRODUCT STORAGE ERROR 1 0.0000
489 MALAISE 5 0.0000
490 TACHYCARDIA 1 0.0000
491 ADVERSE EVENT 1 0.0000
492 OROPHARYNGEAL PAIN 1 0.0000
493 BLOOD GLUCOSE INCREASED 2 0.0000
494 MIGRAINE 1 0.0000
495 INJECTION SITE PAIN 3 0.0000
496 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
497 ILLNESS 1 0.0000
498 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
499 HAEMORRHAGE 1 0.0000
500 PLATELET COUNT DECREASED 1 0.0000
501 DIARRHOEA 6 0.0000
502 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
503 INFLUENZA 1 0.0000
504 SEPSIS 1 0.0000
505 RHEUMATOID ARTHRITIS 1 0.0000
506 SEIZURE 1 0.0000
507 CHILLS 1 0.0000
508 DISEASE PROGRESSION 1 0.0000
509 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
510 VISUAL IMPAIRMENT 1 0.0000
511 OFF LABEL USE 7 0.0000
512 HYPERHIDROSIS 1 0.0000
513 PRODUCT DOSE OMISSION ISSUE 2 0.0000
514 CONDITION AGGRAVATED 2 0.0000
515 PERIPHERAL SWELLING 1 0.0000
516 DRUG INTERACTION 1 0.0000
517 DRUG DEPENDENCE 1 0.0000
518 CONFUSIONAL STATE 1 0.0000
519 PYREXIA 2 0.0000
520 COVID-19 1 0.0000
521 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
522 NO ADVERSE EVENT 1 0.0000
523 ANAEMIA 1 0.0000